{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:09:51Z","timestamp":1790399391028,"version":"4.1.0"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"ORD's Pathfinder Innovation Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science of The Total Environment"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.scitotenv.2012.10.092","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T14:21:46Z","timestamp":1354198906000},"page":"324-337","source":"Crossref","is-referenced-by-count":135,"special_numbering":"C","title":["Lower-dose prescribing: Minimizing \u201cside effects\u201d of pharmaceuticals on society and the environment"],"prefix":"10.1016","volume":"443","author":[{"given":"Christian G.","family":"Daughton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilene Sue","family":"Ruhoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scitotenv.2012.10.092_bb0005","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.scitotenv.2010.02.020","article-title":"Evaluation of the accuracy and consistency of the Swedish Environmental Classification and Information System for pharmaceuticals","volume":"408","author":"\u00c5gerstrand","year":"2010","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0010","article-title":"AGS updated Beers criteria for potentially inappropriate medication use in older adults","author":"AGS","year":"2012"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0015","unstructured":"B\u00e4hr S. Persistenz abwasserb\u00fcrtiger Antipsychotika- und Sulfamethoxazolr\u00fcckst\u00e4nde im Oberfl\u00e4chen-, Grund- und Trinkwasser des s\u00fcdlichen Rhein-Neckar-Kreises [Persistence of wastewater-derived antipsychotics and sulfamethoxazole in surface, ground and drinking water of the Southern Rhine-Neckar District], dissertation, Ruprecht-Karls-Universit\u00e4t, Heidelberg, Germany, 2009, pp 203. Available on: http:\/\/archiv.ub.uni-heidelberg.de\/volltextserver\/volltexte\/2009\/9595\/. (accessed 1 October 2012)."},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0020","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1310\/hpj4312-956","article-title":"Editorial \u2014 data supporting the use of prescription medications for off-label indications","volume":"43","author":"Baker","year":"2008","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconhyd.2010.12.010","article-title":"Occurrence of steroid hormones and antibiotics in shallow groundwater impacted by livestock waste control facilities","volume":"123","author":"Bartelt-Hunt","year":"2011","journal-title":"J Contam Hydrol"},{"issue":"7","key":"10.1016\/j.scitotenv.2012.10.092_bb0030","article-title":"Top 200 drugs of 2011","volume":"78","author":"Bartholow","year":"2012","journal-title":"Pharm Times"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/01.pra.0000396062.12893.5b","article-title":"The impact of evidence-based education on prescribing in a psychiatry residency","volume":"17","author":"Benjamin","year":"2011","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0040","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/jama.2012.362","article-title":"Eliminating waste in US health care","volume":"307","author":"Berwick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0045","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.chemosphere.2012.05.110","article-title":"Investigation of drugs of abuse and relevant metabolites in Dutch sewage water by liquid chromatography coupled to high resolution mass spectrometry","volume":"89","author":"Bijlsma","year":"2012","journal-title":"Chemosphere"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0050","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.chroma.2009.11.062","article-title":"Trace determination of pharmaceuticals and other wastewater-derived micropollutants by solid phase extraction and gas chromatography\/mass spectrometry","volume":"1217","author":"Bisceglia","year":"2010","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ecoenv.2011.11.014","article-title":"An evaluation of free water surface wetlands as tertiary sewage water treatment of micro-pollutants","volume":"78","author":"Breitholtz","year":"2012","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1056\/NEJMp0911423","article-title":"Medicine's ethical responsibility for health care reform \u2014 the top five list","volume":"362","author":"Brody","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0065","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMp1203365","article-title":"From an ethics of rationing to an ethics of waste avoidance","volume":"366","author":"Brody","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11096-008-9260-1","article-title":"A method to include the environmental hazard in drug prescribing","volume":"31","author":"Castensson","year":"2009","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0075","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/es050991m","article-title":"Removal of pharmaceuticals in sewage treatment plants in Italy","volume":"40","author":"Castiglioni","year":"2006","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0080","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1897\/09-173.1","article-title":"Pharmaceutical metabolites in the environment: analytical challenges and ecological risks","volume":"28","author":"Celiz","year":"2009","journal-title":"Environ Toxicol Chem"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0085","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1016\/j.watres.2012.06.017","article-title":"Validation of mega composite sampling and nationwide mass inventories for 26 previously unmonitored contaminants in archived biosolids from the U.S. National Biosolids Repository","volume":"46","author":"Chari","year":"2012","journal-title":"Water Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0090","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/pds.1825","article-title":"U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey","volume":"18","author":"Chen","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0100","first-page":"54","article-title":"Avoiding adverse reactions. Effective lower-dose drug therapies for older patients","volume":"55","author":"Cohen","year":"2000","journal-title":"Geriatrics"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0105","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinte.161.6.880","article-title":"Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference","volume":"161","author":"Cohen","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0110","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archinte.161.7.957","article-title":"Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events","volume":"161","author":"Cohen","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1345\/aph.1A487","article-title":"Why aren't lower, effective, OTC doses available earlier by prescription?","volume":"37","author":"Cohen","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0095","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1158\/1078-0432.CCR-12-0110","article-title":"Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients","volume":"18","author":"Cohen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10408440903373590","article-title":"Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish","volume":"40","author":"Corcoran","year":"2010","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/pds.744","article-title":"Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980\u20131999","volume":"11","author":"Cross","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0130","series-title":"International encyclopedia of public health. 5","first-page":"66","article-title":"Pharmaceuticals as environmental pollutants: the ramifications for human exposure","author":"Daughton","year":"2008"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0135","series-title":"NERL-LV-ESD 10\/081, EPA\/600\/R-10\/106","first-page":"196","article-title":"Drugs and the environment: stewardship & sustainability","author":"Daughton","year":"2010"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0140","series-title":"Contaminants of emerging concern in the environment: ecological and human health considerations","first-page":"9","article-title":"Pharmaceutical ingredients in drinking water: overview of occurrence and significance of human exposure","author":"Daughton","year":"2010"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0145","first-page":"59","article-title":"Illicit drugs: contaminants in the environment and utility in forensic epidemiology","volume":"210","author":"Daughton","year":"2011","journal-title":"Rev Environ Contam Toxicol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0150","series-title":"Environmental contaminants in biota: interpreting tissue concentrations","first-page":"287","article-title":"Active phamaceutical ingredients and aquatic organisms","author":"Daughton","year":"2011"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0155","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1897\/08-382.1","article-title":"Environmental footprint of pharmaceuticals: the significance of factors beyond direct excretion to sewers","volume":"28","author":"Daughton","year":"2009","journal-title":"Environ Toxicol Chem"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/ecp.11.6","article-title":"Green pharmacy and pharmEcovigilance: prescribing and the planet","volume":"4","author":"Daughton","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.watres.2010.08.023","article-title":"Fate of hormones and pharmaceuticals during combined anaerobic treatment and nitrogen removal by partial nitritation-anammox in vacuum collected black water","volume":"45","author":"de Graaff","year":"2011","journal-title":"Water Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0170","article-title":"Sub-therapeutic doses in the treatment of depression: the implications of starting low and going slow","volume":"1","author":"de Jong","year":"2011","journal-title":"J Mind-Body Reg"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0175","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1503\/cmaj.111-2030","article-title":"Lower drug dose may improve outcomes","volume":"183","author":"Dimmitt","year":"2011","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0180","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5694\/j.1326-5377.2009.tb02916.x","article-title":"Low drug doses may improve outcomes in chronic disease","volume":"191","author":"Dimmitt","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0185","first-page":"12","article-title":"Medicine cabinet crackdown: teach patients proper pill-pitching skills","volume":"45","author":"Donini-Lenhoff","year":"2012","journal-title":"CMA Today"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0190","first-page":"3","article-title":"2010 top 200 generic drugs by total prescriptions","author":"Drug Topics","year":"2011"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0195","first-page":"115","article-title":"Liability associated with prescribing medications","volume":"11","author":"Edersheim","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0200","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinternmed.2012.340","article-title":"Drug, patient, and physician characteristics associated with off-label prescribing in primary care","volume":"172","author":"Eguale","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0205","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-2125.2003.01835.x","article-title":"Antibiotic prescribing for children. Too much and too little? Retrospective observational study in primary care","volume":"56","author":"Ekins-Daukes","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0210","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMp1208347","article-title":"France's new framework for regulating off-label drug use","volume":"367","author":"Emmerich","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0215","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1021\/mp2006467","article-title":"Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid","volume":"9","author":"Fagerberg","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.chroma.2012.03.059","article-title":"Analysis of 100 pharmaceuticals and their degradates in water samples by liquid chromatography\/quadrupole time-of-flight mass spectrometry","volume":"1259","author":"Ferrer","year":"2012","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0230","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1021\/es903440m","article-title":"Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents","volume":"44","author":"Fick","year":"2010","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0225","series-title":"Pharmaceuticals","first-page":"56","article-title":"Results from the Swedish National Screening Programme 2010: subreport 3","author":"Fick","year":"2011"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10236244.2012.690579","article-title":"Antidepressants (venlafaxine and citalopram) cause foot detachment from the substrate in freshwater snails at environmentally relevant concentrations","volume":"45","author":"Fong","year":"2012","journal-title":"Mar Freshw Behav Physiol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0240","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1471-4159.2012.07773.x","article-title":"Evidence for the efficacy of statins in animal stroke models: a meta-analysis","volume":"122","author":"Garc\u00eda-Bonilla","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0245","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1001\/archinternmed.2010.355","article-title":"Feasibility study of a systematic approach for discontinuation of multiple medications in older adults","volume":"170","author":"Garfinkel","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0250","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.envint.2008.10.007","article-title":"Disposal practices for unwanted residential medications in the United States","volume":"35","author":"Glassmeyer","year":"2009","journal-title":"Environ Int"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0255","first-page":"119","article-title":"Inappropriate prescribing: Beers criteria, polypharmacy, and drug burden medication management in older adults","author":"Gloth","year":"2010"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0260","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.chroma.2011.02.026","article-title":"Multi-class determination of around 50 pharmaceuticals, including 26 antibiotics, in environmental and wastewater samples by ultra-high performance liquid chromatography\u2013tandem mass spectrometry","volume":"1218","author":"Gracia-Lor","year":"2011","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0265","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archinternmed.2010.90","article-title":"Less is more: how less health care can result in better health","volume":"170","author":"Grady","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0270","first-page":"36","article-title":"Data Diving: what lies untapped beneath the surface of published clinical trial analyses could rock the world of independent review","volume":"26","author":"Grens","year":"2012","journal-title":"Scientist"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0275","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.chroma.2012.05.084","volume":"1248","author":"Gros","year":"2012","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0280","doi-asserted-by":"crossref","first-page":"d7202","DOI":"10.1136\/bmj.d7202","article-title":"Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses","volume":"344","author":"Hart","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0285","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/pds.745","article-title":"Changes in prescribed drug doses after market introduction","volume":"11","author":"Heerdink","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0290","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1002\/jssc.201100540","article-title":"Retrospective LC-QTOF-MS analysis searching for pharmaceutical metabolites in urban wastewater","volume":"34","author":"Hern\u00e1ndez","year":"2011","journal-title":"J Sep Sci"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0295","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/elps.200500693","article-title":"Determination of antidepressants in surface and waste water samples by capillary electrophoresis with electrospray ionization mass spectrometric detection after preconcentration using off-line solid-phase extraction","volume":"27","author":"Himmelsbach","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0300","doi-asserted-by":"crossref","first-page":"w710","DOI":"10.1377\/hlthaff.28.4.w710","article-title":"\u2018Marginal medicine\u2019: targeting comparative effectiveness research to reduce waste","volume":"28","author":"Hoffman","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0305","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd2132","article-title":"Drugs, their targets and the nature and number of drug targets","volume":"5","author":"Imming","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0310","series-title":"Emerging organic contaminants and human health. 20","first-page":"47","article-title":"Pharmaceuticals in drinking water","author":"Jeli\u0107","year":"2012"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0315","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1016\/j.watres.2008.04.026","article-title":"The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK","volume":"42","author":"Kasprzyk-Hordern","year":"2008","journal-title":"Water Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0320","first-page":"219","article-title":"Reducing prescription drug misuse through the use of a citizen mail-back program in Maine \u2014 safe medicine disposal for ME: a handbook and summary report","author":"Kaye","year":"2010"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0325","unstructured":"Lahti M. The fate aspects of pharmaceuticals in the environment: biotransformation, sedimentation and exposure of fish, Academic dissertation, University of Jyv\u00e4skyl\u00e4, Jyv\u00e4skyl\u00e4, Finland, 2012, pp 122. Available on: https:\/\/jyx.jyu.fi\/dspace\/handle\/123456789\/37883. (accessed 1 October 2012)."},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0335","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/etc.1879","article-title":"Bioavailability of pharmaceuticals in waters close to wastewater treatment plants: use of fish bile for exposure assessment","volume":"31","author":"Lahti","year":"2012","journal-title":"Environ Toxicol Chem"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0330","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.chemosphere.2011.06.084","article-title":"Pharmaceuticals in settleable particulate material in urban and non-urban waters","volume":"85","author":"Lahti","year":"2011","journal-title":"Chemosphere"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0340","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.watres.2011.05.042","article-title":"Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment","volume":"45","author":"Lai","year":"2011","journal-title":"Water Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0345","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1016\/j.watres.2012.07.042","article-title":"Distribution of antidepressant residues in wastewater and biosolids following different treatment processes by municipal wastewater treatment plants in Canada","volume":"46","author":"Lajeunesse","year":"2012","journal-title":"Water Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0350","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archinternmed.2009.314","article-title":"Going off-label without venturing off-course: evidence and ethical off-label prescribing","volume":"169","author":"Largent","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0355","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMcibr1202395","article-title":"Toxicity in chemotherapy \u2014 when less is more","volume":"366","author":"Laviano","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0360","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0365","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0370","doi-asserted-by":"crossref","first-page":"d8158","DOI":"10.1136\/bmj.d8158","article-title":"Missing clinical trial data","volume":"344","author":"Lehman","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0375","series-title":"OEI-07-08-00150, US Department of Health and Human Services","first-page":"48","article-title":"Medicare atypical antipsychotic drug claims for elderly nursing home residents","author":"Levinson","year":"2011"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0380","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.watres.2009.09.056","article-title":"Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments","volume":"44","author":"MacLeod","year":"2010","journal-title":"Water Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0385","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/0091270008319794","article-title":"Same drug, different dosing: differences in dosing for drugs approved in the United States, Europe, and Japan","volume":"48","author":"Malinowski","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0390","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ahj.2008.05.032","article-title":"Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial","volume":"156","author":"Mark","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0395","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.chroma.2012.07.038","article-title":"Simultaneous measurement in mass and mass\/mass mode for accurate qualitative and quantitative screening analysis of pharmaceuticals in river water","volume":"1256","author":"Mart\u00ednez Bueno","year":"2012","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0400","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1503\/cmaj.091481","article-title":"Is bigger better? An argument for very low starting doses","volume":"183","author":"McCormack","year":"2011","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0405","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.ijir.3901619","article-title":"\u2018Off-label\u2019 drug use: an FDA regulatory term, not a negative implication of its medical use","volume":"20","author":"Meadows","year":"2008","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0410","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.envpol.2011.11.029","article-title":"Uptake and depuration of pharmaceuticals in aquatic invertebrates","volume":"165","author":"Meredith-Williams","year":"2012","journal-title":"Environ Pollut"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0415","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/etc.27","article-title":"Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed","volume":"29","author":"Metcalfe","year":"2010","journal-title":"Environ Toxicol Chem"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0420","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.envpol.2008.11.045","article-title":"Fate of pharmaceuticals and personal care products in wastewater treatment plants \u2014 conception of a database and first results","volume":"157","author":"Mi\u00e8ge","year":"2009","journal-title":"Environ Pollut"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0425","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/etc.222","article-title":"Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part II: micropollutant removal between wastewater and raw drinking water","volume":"29","author":"Morasch","year":"2010","journal-title":"Environ Toxicol Chem"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0430","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(06)69351-3","article-title":"Drug bulletins: independent information for global use","volume":"368","author":"Olsson","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0435","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/dmd.30.4.430","article-title":"Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects","volume":"30","author":"Patrick","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0440","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0090-9556(24)15366-4","article-title":"Metabolism and excretion of [14C]celecoxib in healthy male volunteers","volume":"28","author":"Paulson","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0445","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/jssc.200700571","article-title":"Simultaneous determination of macrolides, sulfonamides, and other pharmaceuticals in water samples by solid-phase extraction and LC-(ESI) MS","volume":"31","author":"Pedrouzo","year":"2008","journal-title":"J Sep Sci"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0450","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11270-010-0585-8","article-title":"Presence of pharmaceuticals and hormones in waters from sewage treatment plants","volume":"217","author":"Pedrouzo","year":"2011","journal-title":"Water Air Soil Pollut"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0455","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.chemosphere.2010.10.082","article-title":"Removal of estrogens through water disinfection processes and formation of by-products","volume":"82","author":"Pereira","year":"2011","journal-title":"Chemosphere"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0460","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1056\/NEJMp1204493","article-title":"Medication reconciliation for controlled substances \u2014 an \u201cideal\u201d prescription-drug monitoring program","volume":"366","author":"Perrone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0465","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.watres.2008.11.043","article-title":"Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment","volume":"43","author":"Radjenovic","year":"2009","journal-title":"Water Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0470","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.166.9.1021","article-title":"Off-label prescribing among office-based physicians","volume":"166","author":"Radley","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0475","first-page":"1690","article-title":"Chronotherapeutics: an art of dosage form designing","volume":"3","author":"Ravi sankar","year":"2010","journal-title":"J Pharm Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0480","first-page":"99","article-title":"Occurrence of pharmaceuticals, hormones, and organic wastewater compounds in Pennsylvania waters, 2006-09, 2012, SIR 2012-5106","author":"Reif","year":"2012"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0485","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/cn3000422","article-title":"Exploring chemical space for drug discovery using the chemical universe database","volume":"3","author":"Reymond","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0490","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yrtph.2012.06.015","article-title":"Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made?","volume":"64","author":"Rhomberg","year":"2012","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0495","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1377\/hlthaff.2009.1087","article-title":"Medication adherence leads to lower health care use and costs despite increased drug spending","volume":"30","author":"Roebuck","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0500","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.watres.2009.07.004","article-title":"Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation","volume":"44","author":"Rosal","year":"2010","journal-title":"Water Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0505","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/11531440-000000000-00000","article-title":"Cost effectiveness of intensive lipid-lowering treatment for patients with congestive heart failure and coronary heart disease in the US","volume":"28","author":"Rosen","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0510","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJMp1205634","article-title":"Cents and sensitivity \u2014 teaching physicians to think about costs","volume":"367","author":"Rosenbaum","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0515","first-page":"649","article-title":"The case for legal regulation of physicians' off-label prescribing","volume":"86","author":"Rosoff","year":"2011","journal-title":"Notre Dame Law Rev"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0520","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.envint.2008.05.002","article-title":"Beyond the medicine cabinet: an analysis of where and why medications accumulate","volume":"34","author":"Ruhoy","year":"2008","journal-title":"Environ Int"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0525","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.scitotenv.2012.05.017","article-title":"Uptake of pharmaceuticals, hormones and parabens into vegetables grown in soil fertilized with municipal biosolids","volume":"431","author":"Sabourin","year":"2012","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0530","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhazmat.2009.10.100","article-title":"Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment","volume":"175","author":"Santos","year":"2010","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0535","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2011.256","article-title":"Principles of conservative prescribing","volume":"171","author":"Schiff","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0540","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archinternmed.2011.396","article-title":"Communicating uncertainties about prescription drugs to the public: a national randomized trial","volume":"171","author":"Schwartz","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0545","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2125.2004.02228.x","article-title":"Drug development and use in the elderly: search for the right dose and dosing regimen","volume":"58","author":"Shah","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0550","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.watres.2010.09.036","article-title":"Demonstration of 20 pharmaceuticals and personal care products (PPCPs) as nitrosamine precursors during chloramine disinfection","volume":"45","author":"Shen","year":"2011","journal-title":"Water Res"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0555","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archinternmed.2011.437","article-title":"Too little? Too much? Primary care physicians' views on US health care: a brief report","volume":"171","author":"Sirovich","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0560","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/clpt.2012.22","article-title":"Off-label use of drugs and medical devices: a review of policy implications","volume":"91","author":"Stafford","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0565","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1176\/ps.2009.60.3.294","article-title":"Best practices: an intervention to promote evidence-based prescribing at a large psychiatric hospital","volume":"60","author":"Stowell","year":"2009","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0570","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.scitotenv.2008.05.036","article-title":"Occurrence of diclofenac and selected metabolites in sewage effluents","volume":"405","author":"St\u00fclten","year":"2008","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0575","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/11586670-000000000-00000","article-title":"The correct administration of antihypertensive drugs according to the principles of clinical pharmacology","volume":"11","author":"Taddei","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0580","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1289\/ehp.1104650","article-title":"Selective pressure of antibiotic pollution on bacteria of importance to public health","volume":"120","author":"Tello","year":"2012","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0585","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults","volume":"60","author":"The American Geriatrics Society Beers Criteria Update Expert Panel","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0590","article-title":"Dose titration: minimize to maximize","volume":"10","author":"Therapeutics Initiative","year":"1995","journal-title":"Ther Lett"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0595","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF03161014","article-title":"Off-label: just what the doctor ordered","volume":"2","author":"Tomaszewski","year":"2006","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0600","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.292.8.952","article-title":"Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage","volume":"292","author":"Tseng","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0605","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/FTD.0b013e3182489a6f","article-title":"Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study","volume":"34","author":"Uchida","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0610","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.chroma.2010.03.008","article-title":"Multi-residue analysis of pharmaceutical compounds in wastewaters by dual solid-phase microextraction coupled to liquid chromatography electrospray ionization ion trap mass spectrometry","volume":"1217","author":"Unceta","year":"2010","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0615","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.chemosphere.2011.05.014","article-title":"Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid region (Spain) and potential ecotoxicological risk","volume":"84","author":"Valc\u00e1rcel","year":"2011","journal-title":"Chemosphere"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0620","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0625","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.scitotenv.2012.04.028","article-title":"Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment: a review","volume":"429","author":"Verlicchi","year":"2012","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0630","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1592\/phco.28.12.1443","article-title":"Prioritizing future research on off-label prescribing: results of a quantitative evaluation","volume":"28","author":"Walton","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0635","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/009286150503900307","article-title":"Public health care management of water pollution with pharmaceuticals: environmental classification and analysis of pharmaceutical residues in sewage water","volume":"39","author":"Wennmalm","year":"2005","journal-title":"Drug Inf J"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0640","first-page":"75","article-title":"Results from the Swedish screening 2006 subreport 4: pharmaceuticals","author":"Woldegiorgis","year":"2007"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0655","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00216-012-5846-5","article-title":"Determination of pharmaceuticals and antiseptics in water by solid-phase extraction and gas chromatography\/mass spectrometry: analysis via pentafluorobenzylation and stable isotope dilution","volume":"403","author":"Yu","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0645","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.aca.2012.05.057","article-title":"Direct rapid analysis of multiple PPCPs in municipal wastewater using ultrahigh performance liquid chromatography\u2013tandem mass spectrometry without SPE pre-concentration","volume":"738","author":"Yu","year":"2012","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.scitotenv.2012.10.092_bb0650","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.talanta.2011.12.023","article-title":"Analysis of endocrine disrupting compounds, pharmaceuticals and personal care products in sewage sludge by gas chromatography\u2013mass spectrometry","volume":"89","author":"Yu","year":"2012","journal-title":"Talanta"}],"container-title":["Science of The Total Environment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0048969712013927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0048969712013927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T20:01:55Z","timestamp":1745352115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0048969712013927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":131,"alternative-id":["S0048969712013927"],"URL":"https:\/\/doi.org\/10.1016\/j.scitotenv.2012.10.092","relation":{},"ISSN":["0048-9697"],"issn-type":[{"value":"0048-9697","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}